Non-Current Liabilities

Deferred Credits

Abbott Deferred Credits increased by 12.3% to $319.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $284.00M to $319.00M. Over 4 years (FY 2021 to FY 2025), Deferred Credits shows an upward trend with a 5.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase suggests higher future revenue recognition potential, while a decrease may indicate the fulfillment of obligations or a slowdown in advance payments.

Detailed definition

Deferred credits represent obligations where the company has received payment or value for goods or services that have n...

Peer comparison

Common across companies with long-term service contracts or subscription models, often compared as a percentage of total liabilities.

Metric ID: deferred_credits

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$261.00M$260.00M$283.00M$284.00M$319.00M
QoQ Change-0.4%+8.8%+0.4%+12.3%
YoY Change-0.4%+8.8%+0.4%+12.3%
Range$260.00M$319.00M
CAGR+22.2%
Avg YoY Growth+5.3%
Median YoY Growth+4.6%
Current Streak3 quarters growth

Frequently Asked Questions

What is Abbott's deferred credits?
Abbott (ABT) reported deferred credits of $319.00M in Q4 2025.
How has Abbott's deferred credits changed year-over-year?
Abbott's deferred credits increased by 12.3% year-over-year, from $284.00M to $319.00M.
What is the long-term trend for Abbott's deferred credits?
Over 4 years (2021 to 2025), Abbott's deferred credits has grown at a 5.1% compound annual growth rate (CAGR), from $261.00M to $319.00M.
What does deferred credits mean?
Income or revenue received in advance that will be recognized as earnings in future periods.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.